Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 189 Neoplasm Metastasis 19 Neoplasms 9 Ovarian Neoplasms 8 Breast Diseases 6 Triple Negative Breast Neoplasms 4 Prostatic Neoplasms 4 Pancreatic Neoplasms 4 Endometrial Neoplasms 4 Advanced Breast Cancer 4 Neoplasms by Site 3 Lung Neoplasms 3 Hereditary Sensory and Autonomic Neuropathies 3 Head and Neck Neoplasms 3 Colorectal Neoplasms 3 Colonic Neoplasms 3 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Thyroid Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Recurrence 2 Rectal Neoplasms 2 Neoplasm, Residual 2 Multiple Myeloma 2 Melanoma 2 Inflammation 2 Hematologic Neoplasms 2 Fallopian Tube Neoplasms 2 Estrogen Receptor-positive Breast Cancer 2

Interventions

palbociclib 1 Letrozole 1 Fluorouracil 1 Epirubicin 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoadjuvant Operable Breast Cancer × palbociclib × Breast × Clear all

NCT02400567 2022-03-15

NeoPAL

UNICANCER

Phase 2 Completed

Neoadjuvant Operable Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡